Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs Rooti Rx ECG Event Recorder

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Acumen Hypotension Prediction Index – EV1000 Clinical Platform
by Edwards Lifesciences
VS
Rooti Rx ECG Event Recorder
by Rooti Labs Ltd.

AI Verdict

These tools are adjacent rather than direct competitors. Tool A focuses on real-time prediction of hypotensive events and hemodynamic insights in acute care settings, aiding clinicians in preventing intraoperative hypotension. In contrast, Tool B provides continuous, long-term ECG monitoring for up to seven days, primarily for the diagnosis of cardiac events and arrhythmias in a remote or outpatient context.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose Acumen Hypotension Prediction Index if your primary concern is preventing and actively managing acute hypotensive events in high-acuity settings like the operating room or ICU. This tool provides real-time, predictive insights into hemodynamic instability, allowing clinicians to intervene proactively up to 15 minutes before a significant drop in blood pressure occurs. It's ideal for continuous, integrated monitoring where immediate, data-driven decisions are critical to patient safety.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose Rooti Rx ECG Event Recorder if…

Choose Rooti Rx ECG Event Recorder if you need to perform extended, ambulatory cardiac monitoring to detect intermittent arrhythmias or evaluate cardiac symptoms over several days. This wearable device offers convenient, high-resolution ECG recording for up to 7 days, coupled with AI-powered analysis and rapid report generation for efficient diagnosis in outpatient or remote care settings. It's best suited for identifying transient cardiac events that might be missed during shorter, in-clinic examinations.

View Rooti Rx ECG Event Recorder →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Rooti Rx ECG Event Recorder
Pricing Unknown Contact for pricing
Deployment On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform) Cloud-based (RootiCare platform on AWS) and device-based
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rooti Rx ECG Event Recorder

Rooti Rx offers a compact, wearable device for continuous monitoring, emphasizing patient comfort and ease of use for data collection. Its cloud-based platform for online review and editing provides a flexible and accessible workflow for clinicians managing remote patients. In contrast, Acumen HPI is integrated into complex critical care platforms, catering to highly specialized acute care workflows.

Clinical Value

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Acumen HPI provides a significant clinical advantage by predicting hypotensive events up to 15 minutes in advance and offering insights into underlying hemodynamic causes. This real-time, predictive capability allows for proactive intervention in critical care settings, potentially preventing adverse patient outcomes. While Rooti Rx offers valuable diagnostic capabilities, Acumen HPI's preventative and actionable insights in acute care represent a higher immediate impact on patient safety.

Pricing & Value

Tie

Both tools require direct contact for pricing, making a transparent comparison of their cost-effectiveness impossible. Acumen HPI necessitates integration with existing Edwards Lifesciences monitoring platforms and dedicated sensors, suggesting a potentially higher infrastructural investment. Rooti Rx involves device costs and a cloud platform subscription, which could offer different scaling models, but without specific figures, a definitive winner cannot be determined.

Enterprise Readiness

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Edwards Lifesciences, the company behind Acumen HPI, is a large, established medical technology leader with extensive existing infrastructure and relationships within hospitals. Its product is designed for integration with existing critical care platforms, indicating a strong foundation for enterprise-wide deployment and support. Rooti Labs, while offering a cloud-based solution, is a smaller entity and may not possess the same scale of enterprise-level integration and support capabilities.

Innovation

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Acumen HPI demonstrates a higher degree of innovation through its machine learning-based algorithm that not only predicts hypotensive events 15 minutes in advance but also provides actionable insights into the underlying physiological causes. This predictive and prescriptive capability for a critical, time-sensitive condition represents a more advanced application of AI in real-time clinical decision support. Rooti Rx's AI-driven interpretation of wearable ECG data is also innovative but focuses more on diagnostic efficiency rather than real-time predictive intervention.

Support & Docs

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

As a global medical technology company, Edwards Lifesciences is expected to have a comprehensive and robust support infrastructure, including technical assistance, clinical education, and extensive documentation for its products. This level of support and resources is typically more extensive than what a smaller company like Rooti Labs Ltd. might offer, ensuring greater reliability and assistance for enterprise clients.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Rooti Rx ECG Event Recorder
Name Acumen Hypotension Prediction Index – EV1000 Clinical Platform Rooti Rx ECG Event Recorder
Company Edwards Lifesciences Rooti Labs Ltd.
Description The Acumen Hypotension Prediction Index (HPI) software by Edwards Lifesciences uses machine learning to predict hypotensive events up to 15 minutes in advance, providing clinicians with insights into hemodynamic instability and potential causes to help reduce intraoperative hypotension. Rooti Rx is a compact, wearable ECG event recorder that, combined with the AI-powered RootiCare platform, provides continuous cardiac monitoring and rapid, accurate diagnostic reports for medical professionals.
Categories Cardiology AI, Surgical AI, Triage & ER/ICU AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Anesthesiology, Critical Care, Emergency Medicine Cardiology, Family Medicine, Internal Medicine
Key Features HPI Parameter (0-100 likelihood score), Smart Alerts for trending hypotension, Smart Trend screen, Relationship View screen (preload, afterload, contractility insights), Machine learning-based algorithm for prediction, Predicts hypotension up to 15 minutes in advance, Continuous hemodynamic monitoring, Non-invasive (Acumen IQ cuff) and minimally-invasive (Acumen IQ sensor) options Compact wearable ECG device (single or three-channel options), Up to 7-day ECG and actigraphy recording, 24-bit high-resolution ECG images, Mobile telemetry cardiac tags for real-time event marking, AI-driven interpretation and quality assurance checks, Online ECG review and editing via RootiCare platform, Fast report generation within 24 hours, Wi-Fi upload of data to RootiCare database

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and Rooti Rx ECG Event Recorder.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tool A (Acumen HPI) integrates into acute care settings like ORs and ICUs by providing real-time predictive insights into hemodynamic instability, allowing clinicians to proactively intervene to prevent hypotension. Tool B (Rooti Rx) fits into outpatient and diagnostic cardiology workflows by offering continuous cardiac monitoring via a wearable device, enabling rapid and accurate diagnosis of cardiac events within 24 hours of data upload.
Tool A's machine learning algorithm predicts hypotension up to 15 minutes in advance, with an internal validation showing 89% specificity and 90% sensitivity 10 minutes before an event, and an AUC of 0.95. Tool B employs AI-driven interpretation and quality assurance checks for its ECG analysis, with a study on a similar Rooti Labs device demonstrating a 98% average beat per minute correlation with standard 12-lead Holter monitors.
For Tool A, clinicians learn to interpret the HPI score, Smart Alerts, and the Relationship View for hemodynamic insights, with the HPI parameter updating every 20 seconds. For Tool B, the learning curve involves patient education on proper wearable use and clinician familiarity with the RootiCare platform for online ECG review and report generation.
While both tools are HIPAA compliant, specific details on security measures beyond this are not provided. For auditability, Tool A's system would likely track HPI alerts and subsequent clinical interventions, while Tool B's RootiCare platform would log ECG interpretations, report modifications, and user activity, with Rooti Labs stating they undertake monthly checks and random auditing for QA processes.
Deploying Tool A across multiple sites involves integration with existing Edwards Lifesciences HemoSphere or EV1000 platforms and managing dedicated sensor deployment. Tool B's multi-site rollout would focus on managing wearable device distribution and ensuring seamless data upload and access to the cloud-based RootiCare platform for multiple clinics, with flexible options for patient fitting.
For Tool A, EHR integration would ideally involve the automated transfer of continuous hemodynamic parameters and HPI alerts into the patient's record for real-time context and documentation. For Tool B, integration would focus on pushing finalized, AI-interpreted ECG diagnostic reports directly into the patient's chart within the EHR system.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform or Rooti Rx ECG Event Recorder

AI Tool Finder
AI-powered search. Results may not be comprehensive.